Clinical trial
A Phase 2, Randomized, Double-blind, Placebo-controlled Study of TAT4 Gel for the Reduction of Nasolabial Folds
NCT02607670 is registered in ClinicalTrials.gov with Topokine Therapeutics, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 2, Randomized, Double-blind, Placebo-controlled Study of TAT4 Gel for the Reduction of Nasolabial Folds
- Lead sponsor
- Topokine Therapeutics, Inc.
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- January 31, 2016
- Completion date
- September 30, 2016
- Enrollment
- 111 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
nasolabial folds